Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20470 | 397 | 28.8 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1265 | 8379 | CHRONIC LYMPHOCYTIC LEUKEMIA//HAIRY CELL LEUKEMIA//CLL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | T CELL PROLYMPHOCYTIC LEUKEMIA | Author keyword | 21 | 61% | 6% | 22 |
2 | T PLL | Author keyword | 11 | 60% | 3% | 12 |
3 | TCL1 | Author keyword | 9 | 39% | 5% | 19 |
4 | MTCP1 | Author keyword | 9 | 83% | 1% | 5 |
5 | T PROLYMPHOCYTIC LEUKEMIA | Author keyword | 8 | 70% | 2% | 7 |
6 | T CELL LEUKEMIA 1 | Author keyword | 4 | 75% | 1% | 3 |
7 | T CELL PROLYMPHOCYTIC LEUKEMIA T PLL | Author keyword | 4 | 75% | 1% | 3 |
8 | PROLYMPHOCYTIC LEUKEMIA | Author keyword | 3 | 23% | 3% | 13 |
9 | MTCP 1 | Author keyword | 3 | 100% | 1% | 3 |
10 | SPLENIC IRRADIATION | Author keyword | 3 | 30% | 2% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | T CELL PROLYMPHOCYTIC LEUKEMIA | 21 | 61% | 6% | 22 | Search T+CELL+PROLYMPHOCYTIC+LEUKEMIA | Search T+CELL+PROLYMPHOCYTIC+LEUKEMIA |
2 | T PLL | 11 | 60% | 3% | 12 | Search T+PLL | Search T+PLL |
3 | TCL1 | 9 | 39% | 5% | 19 | Search TCL1 | Search TCL1 |
4 | MTCP1 | 9 | 83% | 1% | 5 | Search MTCP1 | Search MTCP1 |
5 | T PROLYMPHOCYTIC LEUKEMIA | 8 | 70% | 2% | 7 | Search T+PROLYMPHOCYTIC+LEUKEMIA | Search T+PROLYMPHOCYTIC+LEUKEMIA |
6 | T CELL LEUKEMIA 1 | 4 | 75% | 1% | 3 | Search T+CELL+LEUKEMIA+1 | Search T+CELL+LEUKEMIA+1 |
7 | T CELL PROLYMPHOCYTIC LEUKEMIA T PLL | 4 | 75% | 1% | 3 | Search T+CELL+PROLYMPHOCYTIC+LEUKEMIA+T+PLL | Search T+CELL+PROLYMPHOCYTIC+LEUKEMIA+T+PLL |
8 | PROLYMPHOCYTIC LEUKEMIA | 3 | 23% | 3% | 13 | Search PROLYMPHOCYTIC+LEUKEMIA | Search PROLYMPHOCYTIC+LEUKEMIA |
9 | MTCP 1 | 3 | 100% | 1% | 3 | Search MTCP+1 | Search MTCP+1 |
10 | SPLENIC IRRADIATION | 3 | 30% | 2% | 7 | Search SPLENIC+IRRADIATION | Search SPLENIC+IRRADIATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AKT KINASE COACTIVATOR | 15 | 71% | 3% | 12 |
2 | MTCP 1 | 7 | 67% | 2% | 6 |
3 | TCL1 | 6 | 36% | 4% | 14 |
4 | 14Q11 | 5 | 63% | 1% | 5 |
5 | PROLYMPHOCYTIC LEUKEMIA | 5 | 14% | 8% | 31 |
6 | PROTOONCOGENE TCL1 | 4 | 47% | 2% | 7 |
7 | T CELL PROLIFERATIONS | 3 | 43% | 2% | 6 |
8 | SPLENIC IRRADIATION | 3 | 26% | 3% | 10 |
9 | T2 14 TRANSLOCATION | 3 | 60% | 1% | 3 |
10 | CHROMOSOME 14 INVERSION | 2 | 32% | 2% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
How I treat prolymphocytic leukemia | 2012 | 24 | 58 | 50% |
The TCL1 family of oncoproteins: Co-activators of transformation | 2005 | 56 | 68 | 57% |
T-cell prolymphocytic leukemia | 2006 | 16 | 23 | 74% |
Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper | 2008 | 27 | 35 | 54% |
T-cell prolymphocytic leukemia | 2009 | 5 | 27 | 78% |
Prolymphocytic leukemias | 2006 | 13 | 34 | 53% |
T-cell prolymphocytic leukemia: A single-institution experience | 2005 | 10 | 29 | 69% |
T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus | 2015 | 0 | 46 | 78% |
Proto-oncogene TCL1: more than just a coactivator for Akt | 2007 | 29 | 97 | 27% |
A Case Report of T Cell Prolymphocytic Leukemia and Kaposi Sarcoma and a Review of T Cell Prolymphocytic Leukemia | 2012 | 1 | 47 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UMR 9955U414 BIOCHIM STRUCT PHARM | 1 | 100% | 0.5% | 2 |
2 | UNITE U462 | 1 | 100% | 0.5% | 2 |
3 | CROYDON EYE UNIT | 1 | 50% | 0.3% | 1 |
4 | DEPARMENT ONCOL | 1 | 50% | 0.3% | 1 |
5 | FUIJSAKI CELL | 1 | 50% | 0.3% | 1 |
6 | JAMES S MCDONNELL GENET | 1 | 50% | 0.3% | 1 |
7 | LUMINY BIOTECH ENTREPRISE | 1 | 50% | 0.3% | 1 |
8 | SDI 401 434 | 1 | 50% | 0.3% | 1 |
9 | UNITE INSERM U462 | 1 | 50% | 0.3% | 1 |
10 | MAT BIOSYST ENGN | 0 | 13% | 0.8% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000171840 | PURE RED CELL APLASIA//T CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA//LARGE GRANULAR LYMPHOCYTE LEUKEMIA |
2 | 0.0000161784 | ATAXIA TELANGIECTASIA//ATM GENE//ATAXIA TELEANGIECTASIA |
3 | 0.0000140805 | T CELL RECEPTOR DELTA//TCRG//IMMUNOL 332 N LAUDERDALE BOX 318 |
4 | 0.0000123349 | T LYMPHOCYTE IMMUNOLOGY//CLIN HOSP O NOVOSEL MED MED//MITOGEN INDUCED CELLULAR CYTOTOXICITY |
5 | 0.0000106426 | FLUDARABINE//CHRONIC LYMPHOCYTIC LEUKEMIA//CLADRIBINE |
6 | 0.0000100561 | RICHTERS SYNDROME//RICHTER SYNDROME//COMPOSITE LYMPHOMA |
7 | 0.0000096898 | ANGIOIMMUNOBLASTIC T CELL LYMPHOMA//PERIPHERAL T CELL LYMPHOMA//ANGIOIMMUNOBLASTIC LYMPHOMA |
8 | 0.0000096364 | CHRONIC LYMPHOCYTIC LEUKEMIA//CLL//B CLL |
9 | 0.0000085168 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
10 | 0.0000070971 | HAIRY CELL LEUKEMIA//HAIRY CELL LEUKAEMIA//HAIRY CELL LEUKEMIA VARIANT |